Ruste, Eustaquio, Jr. L.

HRN: 21-40-99  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/06/2022
06/13/2022
IV
4.5
Q6
Dm Foot Right S/p Aka Right
Waiting Final Action 

Indication:  EmpiricEmpirical Escalation    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: